Blacks Network | Social networking for everyone

2 yrs

Quadriplegia Treatment Market Size, Forecast and Trends | FMI

The quadriplegia treatments market is projected to have a value of US$ 1,468.4 million in 2022. Based on a 4.7% compound annual growth rate (CAGR) between 2022 and 2032, quadriplegia therapy is expected to require approximately US$ 2,324.4 million worldwide by 2032.

The Quadriplegia Treatment Market is witnessing a transformative era as medical advancements and research converge to address the complexities of quadriplegia. The market is characterized by a spectrum of innovative interventions, ranging from cutting-edge therapies to assistive technologies. Rehabilitation strategies, neural regeneration initiatives, and assistive devices are contributing to a holistic approach in enhancing the quality of life for individuals grappling with quadriplegia. As scientific understanding deepens and therapeutic options diversify, the Quadriplegia Treatment Market stands at the forefront of fostering optimism and progress in the pursuit of comprehensive care for those affected by this challenging condition.

The demand for quadriplegia treatment will progressively rise, which will provide manufacturers with numerous favorable development opportunities in the near future.

Key Drivers of Quadriplegia Treatment Market

Quadriplegia is caused by spinal cord injury which is caused due to trauma at the base of the neck or skull. Some of the common causes of quadriplegia, otherwise known as tetraplegia are paralysis after any accident, tumors of the spinal cord or other spinal cord diseases. The injury to the spinal cord may cause partial or total limb paralysis.

Get a Sample Copy of the Report:
https://www.futuremarketinsigh....ts.com/reports/sampl

According to 2020 data sheet of Spinal Cord Injury Statistics, it was estimated that approximately 17,810 new cases of spinal cord injuries occur every year in the U.S. Some of the reasons for quadriplegia include stroke, vehicular accidents, falls, violence, sports, medical or surgical causes and others.

According to WHO statistics, published in June 2021, 20-50 million people suffer from road traffic accidents every year which lead to non-fatal injuries yet permanent disabilities to them. With the increasing rate of road traffic accidents, the demand for quadriplegia treatment is set to show a positive growth over the forecast period.

Recent technological advancements and various R&D activities in the field of quadriplegia treatment are one of the leading causes which will boost the demand for this market in forthcoming years. There is an increased level of awareness amongst the patients suffering from spinal cord injuries about various treatment options available to improve their quality of life. This is another factor which will propel the demand for various treatments for quadriplegia during the forecast market.

Electrical Stimulation: Revolutionary Technique that Got Quadriplegic People Back on their Feet.

Electrical stimulators which were originally designed to treat chronic pain helped more than a dozen patients with quadriplegia to wiggle their toes, flex their legs or even walk with support.

This was a revolutionary technique which was conducted in the lab of University of Louisville in Kentucky. Electrical stimulation thus made promising and huge gains for people with paralysis wanting to regain their functionalities. The study was published in July 2019, after which thousands of patients have enrolled in the wait lists for the electrical stimulation technique.

Elevate Strategy: Tap into Analyst Expertise Now:
https://www.futuremarketinsigh....ts.com/ask-question/

U.S. and Canada Quadriplegia Treatment: Regional Outlook

U.S. and Canada region was found to be the largest market for the diagnosis and treatment of spinal cord injury (SCI). Increasing awareness and advanced technologies are the main drivers of this market. Most of the accidents found that alcohol was one of the most important factors; that is, approximately 25% of spinal cord injuries.

In the United States, the average annual medical cost for treating an acute spinal cord injury has been found to be in the range of $ 15,000 to $ 30,000 per year. All these factors are expected to drive the market growth of quadriplegia treatment market and offer lucrative opportunities for the providers.

Europe Quadriplegia Treatment: Regional Outlook

Europe was observed to be the second largest market, region wise for the quadriplegia treatment industry. Some of the factors contributing to this large market share are the presence of leading research institutes in the region for various neurological disease diagnosis and treatment. Increased awareness regarding various new technologies which help the quadriplegic patients lead a relatively normal life is also another key driver for this industry in Europe.

Key player:

Major manufacturers of medications needed to treat quadriplegia are

Merck & Co.
Sanofi Pharmaceuticals
Baxter International
Zydus Cadila
GlaxoSmithKline
AstraZeneca
Cipla
Johnson & Johnson
Bristol Myers Squibb Co.
Eli Lily & Co.
Teva Pharmaceuticals
Takeda Pharmaceutical Co Ltd
Hoffmann La Roche
Sun Pharmaceuticals.
In November 2020, Pfizer and Mylan announced the merger of Pfizer’s Upjohn generics unit and Mylan. This deal was a part of a restructuring drive at Pfizer, which was aimed at a stronger foothold in the innovative medicines division of the company.

Key Segments:

By Treatment Type:

Corticosteroids
Non- Steroidal Anti-inflammatory Drugs (NSAIDs)
Antidepressants
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin and norepinephrine reuptake inhibitors (SNRIs)
Anticonvulsants
Narcotic Analgesics
Antispasmodics & Muscle Relaxants
Antibiotics
By Route of Administration:

Oral
Intravenous
Others
By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Stores?

Comment

Who is in your network?

Discover posts

Perm or Color First: Which One Should You Do? | Apohair